Eliza Gratiela Popa
Overview
Explore the profile of Eliza Gratiela Popa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abu Koush A, Popa E, Pricop D, Nita L, Foia C, Pauna A, et al.
Pharmaceutics
. 2025 Jan;
16(12.
PMID: 39771553
Background: Lipid vesicles, especially those utilizing biocompatible materials like chitosan (CHIT), hold significant promise for enhancing the stability and release characteristics of drugs such as indomethacin (IND), effectively overcoming the...
2.
Hilitanu L, Mititelu-Tartau L, Popa E, Buca B, Gurzu I, Fotache P, et al.
Molecules
. 2024 Jan;
29(1).
PMID: 38202640
Our study was designed to acquire, characterize and evaluate the biocompatibility of novel lipid vesicles loaded with acetaminophen (APAP) and coated with chitosan (CS). We investigated the in vitro and...
3.
Anton I, Mititelu-Tartau L, Popa E, Poroch M, Poroch V, Pelin A, et al.
Medicina (Kaunas)
. 2022 Nov;
58(11).
PMID: 36363577
: Diabetes mellitus (DM) is a complex disease affecting the whole metabolic balance of the body and resulting in multiple organ complications: cardiovascular, neuronal, renal, etc. Our study focuses on...
4.
Anton I, Mititelu-Tartau L, Popa E, Poroch M, Poroch V, Pintilei D, et al.
Healthcare (Basel)
. 2022 Jul;
10(7).
PMID: 35885680
(1) Background. We aimed to assess long-term efficacy and safety in inadequately controlled type 2 diabetes (T2DM) of two SGLT-2 inhibitors: empagliflozin (Empa) and dapagliflozin (Dapa), combined with metformin, other...
5.
Mititelu-Tartau L, Bogdan M, Pricop D, Buca B, Hilitanu L, Pauna A, et al.
Polymers (Basel)
. 2021 Apr;
13(7).
PMID: 33805954
Method: The liposomes were prepared by entrapping dexketoprofen in vesicular systems stabilized with chitosan. The in vivo biocompatibility was evaluated after oral administration in white Wistar rats: Group I (DW):...
6.
Tartau L, Bogdan M, Buca B, Pauna A, Tartau C, Dijmarescu L, et al.
Medicina (Kaunas)
. 2021 Feb;
57(2).
PMID: 33557245
: The selective kappa opioid receptor agonist U50,488 was reported to have analgesic, cough suppressant, diuretic and other beneficial properties. The aim of our study was to analyze the effects...
7.
Boanca M, Popa E, Lupusoru R, Poroch V, Mititelu-Tartau L, Lupusoru C
Rev Med Chir Soc Med Nat Iasi
. 2014 Oct;
118(3):847-53.
PMID: 25341311
Aim: The study investigates the effects of magnesium nanovesicles on the memory processes performance in mice. Materials And Methods: L-a-phosphatidylcholine was used to obtain nano formulations as lipid vesicles systems...
8.
Tartau L, Popa E, Lupusoru R, Lupusoru C, Stoleriu I, Ochiuz L
Pharmacology
. 2014 Jul;
93(5-6):253-9.
PMID: 25059844
Background/aims: The present study investigates the effects of pregabalin (PGB), acetaminophen (ACET) and tenoxicam (TNX) administration in somatic and visceral nociception, using the tail flick test and the writhing test...